Regenerative MedicineClinical TrialPaywall

Tight Blood Sugar Control Boosts Heart Stem Cells After Heart Attack

Study shows intensive glucose management increases cardiac stem cells in heart attack patients, potentially improving recovery.

Saturday, March 28, 2026 0 views
Published in ClinicalTrials.gov
Clinical trial visualization: Tight Blood Sugar Control Boosts Heart Stem Cells After Heart Attack

Summary

Researchers studied whether tight blood sugar control could boost the heart's natural repair mechanisms after a heart attack. They followed 65 heart attack patients undergoing bypass surgery, comparing those with normal blood sugar to those with high blood sugar who received either intensive or standard glucose control. The intensive group aimed for blood sugar levels between 80-140 mg/dl using insulin therapy. Scientists measured cardiac stem cells, oxidative stress, and cell death in heart tissue samples. This research explores how metabolic control might enhance the heart's regenerative potential during recovery from acute damage.

Detailed Summary

This completed clinical trial investigated whether tight glycemic control could enhance the heart's natural regenerative capacity following acute myocardial infarction. The study addressed a critical gap in understanding how blood sugar management affects cardiac stem cell activity during heart attack recovery.

Researchers enrolled 65 patients experiencing their first heart attack who required coronary bypass surgery. The study design included 25 normoglycemic patients as controls, while 40 hyperglycemic patients were randomized into two groups: intensive glycemic control targeting 80-140 mg/dl or conventional control targeting 180-200 mg/dl. Treatment lasted three days before surgery using insulin infusion followed by subcutaneous insulin.

The team measured multiple cardiac health markers including echocardiographic parameters, oxidative stress indicators, cell death markers, and most importantly, cardiac stem cells in tissue samples from the peri-infarcted area. They specifically analyzed c-kit, MDR1, and Sca-1 positive cells, which represent different populations of cardiac stem cells crucial for heart repair.

While the trial's completion status indicates data collection finished, the specific results regarding stem cell enhancement aren't detailed in this summary. However, the study's design suggests important implications for post-heart attack care protocols. If tight glycemic control indeed increases cardiac stem cells, this could revolutionize recovery strategies and potentially improve long-term heart function outcomes. This research contributes valuable insights into the intersection of metabolic health and cardiovascular regeneration, offering potential pathways for optimizing heart attack recovery through precise blood sugar management.

Key Findings

  • Tight glycemic control may increase cardiac stem cell populations after heart attack
  • Intensive glucose management targeted 80-140 mg/dl versus conventional 180-200 mg/dl
  • Study measured cardiac stem cells, oxidative stress, and cell death in heart tissue
  • Research focused on regenerative potential during acute myocardial infarction recovery

Methodology

Randomized controlled trial with 65 participants experiencing first heart attack requiring bypass surgery. Study duration was 8 years (2001-2009) with 3-day intensive treatment periods. Controls included normoglycemic patients and conventional glycemic management groups.

Study Limitations

Small sample size of 65 patients limits generalizability. Study focused only on patients requiring bypass surgery, excluding other heart attack presentations. Long study duration may introduce variability in treatment protocols over time.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.